Shashi Tharoor of the Congress tweeted: “Covaxin has not yet had Phase 3 trials. Approval was premature and could be dangerous.” The Congress party today...
Covaxin is one of the three vaccines for which emergency approval has been sought from the Drug Controller General of India. Hyderabad| India’s wait...
Emergency use authorization has not been granted to Serum Institute of India (SII) and Bharat Biotech’s Covid-19 vaccines over lack of data, sources told News18...
The clarification came shortly after Haryana Health Minister Anil Vij, who took the vaccine shot in the third phase of vaccine trials, tested positive for...
Recently, reports came out that adverse event was reported in Bharat Biotech’s Covaxin trials. This occurred during the Phase I trials in August. Sonipat|...
Earlier in September, Union Health Minister Dr Harsh Vardhan had said that there are expectations a vaccine for coronavirus will be available in the country...
The Hyderabad-based vaccine maker has received approval for phase 3 trials and will enroll 26,000 volunteers for the late-stage testing in November. Covaxin, the ICMR-backed...